News: CDX Cardiex Subsidiary ATCOR Partners With Invaryant To Enable Clinical Trials, page-3

It is good to see our proprietary data & metrics from CONNEQT Pulse already being integrated into 3rd party platforms. I'm guessing there will be several such partnerships throughout 2023. A quick look at the Invaryant LinkedIn page tells me they have had a focus around maternal care, hypertension through pregnancy and predicting conditions such as preeclampsia. I can see how we would be a good fit to their existing knowledge base.
Hopefully there is a large pharmaceutical company in the wings, wanting a decentralised trial around maternal care, looking at both CONNEQT Pulse and our metrics, and also wanting the Invaryant metrics .... hey presto !

I do like this comment

"The Pulse device will be available for healthcare research and clinical trials in early 2023."

Not " expect to be available "